Loading…
Rocket Pharmaceuticals develops gene therapies for rare genetic diseases using lentiviral and adeno-associated viral platforms. The company focuses on curing bone marrow-derived and cardiovascular conditions with high unmet medical needs.
AI named Rocket Pharmaceuticals from November 2025 to March 2026.